• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

庆大霉素治疗梅尼埃病的前庭和听力学功能

Vestibular and audiologic functions in gentamicin-treated Menière's disease.

作者信息

Möller C, Odkvist L M, Thell J, Larsby B, Hydén D

机构信息

Boys Town National Institute, Omaha, Nebraska.

出版信息

Am J Otol. 1988 Sep;9(5):383-91.

PMID:3202127
Abstract

Fifteen patients with disabling Meniere's disease were treated with local intratympanic administration of gentamicin once daily. They had suffered from frequent attacks of vertigo and vomiting, the hearing in the affected ears was decreased permanently, and spontaneous nystagmus was observed. The number of treatment days ranged between 3 and 11. Follow-up time was 1 to 6 years. For evaluation of the treatment, audiologic and vestibular examinations were used, including the broad frequency-band rotatory test (0.4-4.5 Hz). Fourteen patients were free from vertigo after treatment. In 5 patients, there was an increased hearing loss, and in 10 it remained unchanged. Tinnitus and fullness sensations were diminished. After treatment, all ears were unresponsive to caloric stimulation. The clinical examination and rotatory testing in light with sinusoidal stimulation revealed good central compensation of the vestibular loss. However, with pseudorandomized oscillations in darkness, the broad frequency-band rotatory test quantified the loss of peripheral vestibular function and was able to detect the side of the lesion in eight of nine patients.

摘要

15例梅尼埃病致残患者接受了鼓室内局部注射庆大霉素治疗,每日1次。他们频繁发作眩晕和呕吐,患耳听力永久性下降,并观察到自发性眼球震颤。治疗天数为3至11天。随访时间为1至6年。为评估治疗效果,采用了听力学和前庭检查,包括宽频带旋转试验(0.4 - 4.5Hz)。14例患者治疗后眩晕消失。5例患者听力损失加重,10例患者听力无变化。耳鸣和胀满感减轻。治疗后,所有患耳对冷热试验均无反应。临床检查和正弦刺激下的旋转试验显示前庭功能丧失得到了良好的中枢代偿。然而,在黑暗中进行伪随机振荡时,宽频带旋转试验量化了外周前庭功能的丧失,并能够在9例患者中的8例中检测到病变侧。

相似文献

1
Vestibular and audiologic functions in gentamicin-treated Menière's disease.庆大霉素治疗梅尼埃病的前庭和听力学功能
Am J Otol. 1988 Sep;9(5):383-91.
2
Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.梅尼埃病患者鼓室内注射庆大霉素治疗结束时的前庭功能
J Vestib Res. 2005;15(1):49-58.
3
Intratympanic gentamicin for intractable Meniere's disease.鼓室内注射庆大霉素治疗难治性梅尼埃病。
Laryngoscope. 2003 Mar;113(3):456-64. doi: 10.1097/00005537-200303000-00013.
4
Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.在梅尼埃病患者中使用市售的局部用庆大霉素-倍他米松耳滴剂有意破坏前庭功能:局部耳滴剂耳毒性的进一步证据。
Laryngoscope. 2002 Apr;112(4):689-95. doi: 10.1097/00005537-200204000-00018.
5
Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.鼓室内庆大霉素治疗伴正常听力的梅尼埃病患者。
Otolaryngol Head Neck Surg. 2010 Apr;142(4):570-5. doi: 10.1016/j.otohns.2009.12.009.
6
Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.经鼓膜庆大霉素与纤维蛋白组织粘合剂治疗单侧梅尼埃病:对前庭功能的影响
Otolaryngol Head Neck Surg. 2005 Dec;133(6):929-35. doi: 10.1016/j.otohns.2005.07.033.
7
Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.鼓室内注射庆大霉素治疗难治性梅尼埃病后与眩晕控制及听力变化相关的因素
Otol Neurotol. 2006 Sep;27(6):896-900. doi: 10.1097/01.mao.0000227663.79210.c1.
8
[Curative effect of transtympanic perfusion of gentamicin on unilateral Ménière's disease].
Zhonghua Yi Xue Za Zhi. 2003 Aug 10;83(15):1356-8.
9
Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.接受鼓室内注射庆大霉素治疗梅尼埃病患者的长期听力转归
Laryngoscope. 2003 May;113(5):815-20. doi: 10.1097/00005537-200305000-00009.
10
Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.前庭诱发肌源性电位测试在评估梅尼埃病鼓室内庆大霉素治疗中的可靠性。
Acta Otolaryngol. 2008 Apr;128(4):422-6. doi: 10.1080/00016480701808988.

引用本文的文献

1
Intratympanic gentamycine for Ménière's disease: is there a selective vestibulotoxic effect?鼓室内庆大霉素治疗梅尼埃病:是否存在选择性前庭毒性作用?
Eur Arch Otorhinolaryngol. 2020 Jul;277(7):1949-1954. doi: 10.1007/s00405-020-05901-3. Epub 2020 Mar 30.
2
Intratympanic Gentamicin for Intractable Ménière's Disease - A Review and Analysis of Audiovestibular Impact.鼓室内注射庆大霉素治疗难治性梅尼埃病——听觉前庭影响的综述与分析
Int Arch Otorhinolaryngol. 2018 Apr;22(2):190-194. doi: 10.1055/s-0037-1604064. Epub 2017 Jul 17.
3
Intratympanic (IT) Therapies for Menière's Disease: Some Consensus Among the Confusion.
梅尼埃病的鼓室内治疗:混乱中的一些共识
Curr Otorhinolaryngol Rep. 2017 Jun;5(2):132-141. doi: 10.1007/s40136-017-0153-5. Epub 2017 May 3.
4
Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method.按需鼓室内给予庆大霉素治疗梅尼埃病。使用 Kaplan-Meier 方法进行的长期分析。
Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1443-9. doi: 10.1007/s00405-013-2597-7. Epub 2013 Jun 19.
5
Low-dose intratympanic gentamicin treatment of Menière's disease.
Eur Arch Otorhinolaryngol. 1994;251 Suppl 1:S12-4. doi: 10.1007/BF02565212.
6
Meniere's Syndrome.梅尼埃病
Curr Treat Options Neurol. 1999 Mar;1(1):57-67. doi: 10.1007/s11940-999-0033-5.